UNRESTRICTED STOCK AWARD AGREEMENT UNDER THE FATE THERAPEUTICS, INC. 2013 STOCK OPTION AND INCENTIVE PLANUnrestricted Stock Award Agreement • January 7th, 2015 • Fate Therapeutics Inc • Biological products, (no disgnostic substances)
Pursuant to the Fate Therapeutics, Inc. 2013 Stock Option and Incentive Plan (the “Plan”) as amended through the date hereof, Fate Therapeutics, Inc. (the “Company”) hereby grants an Unrestricted Stock Award (an “Award”) to the Grantee named above. Upon acceptance of this Award, the Grantee shall receive the number of shares of Common Stock, par value $0.001 per share (the “Stock”) of the Company specified above, subject to the restrictions and conditions set forth herein and in the Plan. The Company acknowledges the receipt from the Grantee of consideration with respect to the par value of the Stock in the form of cash, past or future services rendered to the Company by the Grantee or such other form of consideration as is acceptable to the Administrator.
